Home » Topics » BioWorld

BioWorld
RSS

TSI RAISES $25 MILLION IN OFFERING

Jan. 29, 1992

FDA APPROVES ELAN'S NICOTINE PATCH

Jan. 29, 1992

TRIPLEX TO CO-DEVELOP DRUGS WITH HOECHST

Jan. 29, 1992

GYNEX TO USE VA DATA IN FDA REVIEW

Jan. 28, 1992

CYTRX TO REDEEM CLASS B WARRANTS

Jan. 28, 1992

UNIGENE PLANS CALCITONIN SALES

Jan. 28, 1992

DNAP TO ACQUIRE JOINT VENTURE

Jan. 28, 1992

YAMANOUCHI TO SELL ABS TEST KITS

Jan. 28, 1992

STEM CELL CONCENTRATOR SUCCESSFUL IN TESTS

Jan. 28, 1992

INSITE TO EYE SYNERGEN'S ANTRIL

Jan. 28, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...